These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10928153)

  • 1. A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.
    Würl P; Lautenschläger C; Meye A; Schmidt H; Bache M; Rath FW; Schönfelder M; Taubert H
    Anticancer Res; 2000; 20(3B):2065-72. PubMed ID: 10928153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
    Würl P; Meye A; Schmidt H; Lautenschläger C; Kalthoff H; Rath FW; Taubert H
    Oncogene; 1998 Mar; 16(9):1183-5. PubMed ID: 9528860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
    Würl P; Meye A; Berger D; Bache M; Lautenschläger C; Schmidt H; Kalthoff H; Rath FW; Taubert H
    Diagn Mol Pathol; 1997 Oct; 6(5):249-54. PubMed ID: 9458382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
    Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
    Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
    Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
    Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
    Weitz J; Antonescu CR; Brennan MF
    J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
    Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
    J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
    Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
    Pol J Pathol; 1999; 50(1):9-16. PubMed ID: 10412269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.
    Stojadinovic A; Leung DH; Hoos A; Jaques DP; Lewis JJ; Brennan MF
    Ann Surg; 2002 Mar; 235(3):424-34. PubMed ID: 11882765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.
    Heslin MJ; Lewis JJ; Nadler E; Newman E; Woodruff JM; Casper ES; Leung D; Brennan MF
    J Clin Oncol; 1997 Aug; 15(8):2832-9. PubMed ID: 9256126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical therapy of abdominal and trunk soft tissue sarcomas].
    Schimmack S; Büchler MW; Weitz J
    Chirurg; 2009 Mar; 80(3):202-8. PubMed ID: 19221701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapy of retroperitoneal soft tissue sarcomas].
    Siewert JR; Roder JD; Fink U
    Chirurg; 1993 Jul; 64(7):527-34. PubMed ID: 8375202
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
    Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
    Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
    Antonescu CR; Leung DH; Dudas M; Ladanyi M; Brennan M; Woodruff JM; Cordon-Cardo C
    Am J Pathol; 2000 Mar; 156(3):977-83. PubMed ID: 10702413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.
    van Dalen T; Hennipman A; Van Coevorden F; Hoekstra HJ; van Geel BN; Slootweg P; Lutter CF; Brennan MF; Singer S
    Ann Surg Oncol; 2004 May; 11(5):483-90. PubMed ID: 15078637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors associated with primary retroperitoneal sarcoma.
    Qiao MZ; Li CL
    Bull Cancer; 2007 Jan; 94(1):E5-7. PubMed ID: 17236999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.